Genome-wide association study of white-coat effect in hypertensive patients

Jenni M. Rimpelä, Teemu Niiranen, Antti Jula, Ilkka Pörsti, Antti J. Tikkakoski, Aki Havulinna, Terho Lehtimäki, Veikko Salomaa, Kimmo K. Kontula, Timo P. Hiltunen

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review


Background: White-coat effect (WCE) confounds diagnosis and treatment of hypertension. The prevalence of white-coat hypertension is higher in Europe and Asia compared to other continents suggesting that genetic factors could play a role.Methods: To study genetic variation affecting WCE, we conducted a two-stage genome-wide association study involving 1343 Finnish subjects. For the discovery stage, we used Genetics of Drug Responsiveness in Essential Hypertension (GENRES) cohort (n=206), providing the mean WCE values from up to four separate office/ambulatory recordings conducted on placebo. Associations with p values

TidskriftBlood Pressure
Sidor (från-till)239-249
Antal sidor11
StatusPublicerad - 2019
MoE-publikationstypA1 Tidskriftsartikel-refererad


  • 3121 Inre medicin

Citera det här